Urinary proteomic profiles distinguish between active and inactive lupus nephritis

K Mosley, FWK Tam, RJ Edwards, J Crozier… - …, 2006 - academic.oup.com
Objectives. Key aims of the treatment of lupus nephritis (LN) are to induce and maintain
remission with minimal side effects. However, assessing ongoing renal inflammatory activity …
被引用次数：140 相关文章
[PDF] researchgate.net

[PDF][PDF] Urinary proteomic profiles distinguish between active and inactive lupus nephritis

K Mosley, FWK Tam, RJ Edwards, J Crozier… - J Am Soc …, 2005 - researchgate.net
Objectives. Key aims of the treatment of lupus nephritis (LN) are to induce and maintain
remission with minimal side effects. However, assessing ongoing renal inflammatory activity …

Urinary proteomic profiles distinguish between active and inactive lupus nephritis

K Mosley, FWK Tam, RJ Edwards, J Crozier, CD Pusey… - Rheumatology, 2006 - elibrary.ru
Objectives. Key aims of the treatment of lupus nephritis (LN) are to induce and maintain
remission with minimal side effects. However, assessing ongoing renal inflammatory activity …

[引用][C] Urinary proteomic profiles distinguish between active and inactive lupus nephritis

K MOSLEY, FWK TAM, RJ EDWARDS… - Rheumatology …, 2006 - pascal-francis.inist.fr
Urinary proteomic profiles distinguish between active and inactive lupus nephritis CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

Urinary proteomic profiles distinguish between active and inactive lupus nephritis.

K Mosley, FW Tam, RJ Edwards, J Crozier… - Rheumatology …, 2006 - europepmc.org
Objectives Key aims of the treatment of lupus nephritis (LN) are to induce and maintain
remission with minimal side effects. However, assessing ongoing renal inflammatory activity …
[PDF] academia.edu

[PDF][PDF] Urinary proteomic profiles distinguish between active and inactive lupus nephritis

K Mosley, FWK Tam, RJ Edwards, J Crozier… - J Am Soc …, 2005 - academia.edu
Objectives. Key aims of the treatment of lupus nephritis (LN) are to induce and maintain
remission with minimal side effects. However, assessing ongoing renal inflammatory activity …

Urinary proteomic profiles distinguish between active and inactive lupus nephritis

K Mosley, FWK Tam, RJ Edwards… - Rheumatology …, 2006 - pubmed.ncbi.nlm.nih.gov
Objectives Key aims of the treatment of lupus nephritis (LN) are to induce and maintain
remission with minimal side effects. However, assessing ongoing renal inflammatory activity …
[PDF] semanticscholar.org

[PDF][PDF] Urinary proteomic profiles distinguish between active and inactive lupus nephritis

K Mosley, FWK Tam, RJ Edwards… - J Am Soc …, 2005 - pdfs.semanticscholar.org
Objectives. Key aims of the treatment of lupus nephritis (LN) are to induce and maintain
remission with minimal side effects. However, assessing ongoing renal inflammatory activity …
[PDF] psu.edu

[PDF][PDF] Urinary proteomic profiles distinguish between active and inactive lupus nephritis

K Mosley, FWK Tam, RJ Edwards, J Crozier… - J Am Soc Nephrol, 2005 - Citeseer
Objectives. Key aims of the treatment of lupus nephritis (LN) are to induce and maintain
remission with minimal side effects. However, assessing ongoing renal inflammatory activity …

[引用][C] Urinary proteomic profiles distinguish between active and inactive lupus nephritis

K Mosley, FWK Tam, RJ Edwards, J Crozier, CD Pusey… - Rheumatology, 2006 - cir.nii.ac.jp
Urinary proteomic profiles distinguish between active and inactive lupus nephritis | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学 …